We get it
(4) There is suggestion amongst researchers that Tesamorelin & CJC-1295 (Mod GRF 1-29) might promote the generation of cyclic adenosine monophosphate (cAMP) within specific target cells
Ask our front desk about current options when you come in
received advisory/consulting fees and/or other support from Altimmune, AstraZeneca, Bayer, Biomea, Boehringer Ingelheim, Carmot Therapeutics, Cytoki Pharma, Eli Lilly, Intercept, Janssen/Johnson & Johnson, Mannkind, Mediflix, Merck, Metsera, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Sanofi, Shionogi, Structure Therapeutics, Target RWE, Terns Pharmaceuticals, The Comm Group, Valeritas, WebMD and Zealand Pharma
To learn more about our research disclaimers please visit our page Research-only disclaimer
[PMID: 19805566] PubMed record related to this compound for laboratory literature review